Danaher's Beckman Coulter Wins FDA Clearance for Bacterial-Viral Infection Test

By Public Technologies
  • Danaher unit Beckman Coulter Diagnostics received FDA clearance for its Access MeMed BV blood test to distinguish bacterial from viral infections.
  • Cleared for adults and children aged 90 days or older, the assay delivers results in as little as 15 minutes.
  • Testing uses existing DxI 9000 and Access 2 analyzers without requiring new instruments or workflow changes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611030830PR_NEWS_USPR_____LA87215) on November 03, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk